No information is available on glasdegib during breastfeeding. It is 91% bound to plasma proteins, so amounts in milk are likely to be low. With a half-life of 17.4 hours, it is likely to be eliminated from milk by 4 to 7 days after the last dose. However, the manufacturer recommends that breastfeeding be discontinued during glasdegib therapy and for at least 30 days after the last dose.
关于格拉斯吉布在母乳喂养期间的信息尚无可用资料。它与血浆蛋白的结合率为91%，因此乳汁中的含量可能较低。其半衰期为17.4小时，末次给药后4至7天可能会从乳汁中消除。然而，制造商建议在格拉斯吉布治疗期间及末次给药后至少30天内停止母乳喂养。
